Abstract Chlamydophila pneumoniae is a common respiratory pathogen that has been shown to be associated with coronary artery disease. Recent studies have shown that one of the possible mechanisms of the atherogenicity of C. pneumoniae is overexpression of cell adhesion molecules (CAMs) in infected endothelial cells. We investigated whether exposure of C. pneumoniae -infected endothelial cells to oxidized LDL (oxLDL) leads to further upregulation of CAMs. 
During the past decade, several investigators have linked inflammation to atherogenesis and plaque disruption, and the concept that atherosclerosis is a chronic inflammatory process became well established (1, 2) . Atherosclerotic plaques are known to contain not only lipids but also a heavy infiltrate of inflammatory cells (macrophages, T-lymphocytes) as well as smooth muscle cells and extracellular matrix (3, 4) . The earliest step, however, in the sequence of events that leads to the development of the inflammatory reaction associated with atherosclerosis is endothelial dysfunction that starts with the upregulation of adhesion molecules (5, 6) . That, in turn, promotes the attraction and adherence of monocytes and T lymphocytes to the endothelium, which is an essential first step in the formation of a perivascular inflammatory infiltrate (4, 6) .
Of the multiple factors that contribute to the overexpression of adhesion molecules in the endothelium, modified lipoproteins, including oxidized LDL (oxLDL), have been the object of considerable attention. The incubation of macrophages with oxLDL results in the release of proinflammatory cytokines such as interleukin-1 and tumor necrosis factor (TNF), which are known to upregulate the expression of cell adhesion molecules (CAMs) (7) (8) (9) (10) (11) . Another factor known to cause increased expression of cell adhesion molecules in the endothelium is Chlamydophila pneumoniae infection (12) .
C. pneumoniae is one of the infectious agents most frequently associated with the presence of atherosclerosis and acute cardiovascular events. A role for C. pneumoniae in the pathogenesis of atherosclerosis was first suggested in 1988 by Saikku et al. (13) , who demonstrated that patients with coronary artery disease were more likely to have serologic evidence of a previous C. pneumoniae infection than were matched controls. Several groups have demonstrated the presence of the organism in atherosclerotic plaques using various techniques, such as ELISA, PCR, electron microscopy, immunohistochemistry, and isolation in tissue culture (14) (15) (16) (17) . The presence of circulating C. pneumoniae -specific immune complexes in a high proportion of coronary heart disease patients suggests the persistence of a chronic infection (18, 19) . However, none of these lines of evidence can be considered as proof of a causal relationship between C. pneumoniae and atherosclerosis.
The definition of mechanisms that could explain how C. pneumoniae might trigger or perpetuate perivascular inflammatory reactions is critical for establishing the pathogenic role of C. pneumoniae . The upregulation of CAMs in C. pneumoniae -infected endothelial cells has been proposed as one of the possible mechanisms (12) because it promotes the rolling and attachment of circulating leukocytes to endothelial cells, leading to the transmigration of monocytes into the subendothelial space (20) (21) (22) . C. pneumoniae infection may also contribute to inflammation by enhancing oxidative stress and, as a consequence, oxidative modification of proteins, including LDL (23) . Here, we investigate the possible synergism of C. pneumoniae infection and oxidized LDL on the expression of CAMs by endothelial cells.
MATERIALS AND METHODS

Cell cultures
Hep-2 cells [American Type Culture Collection (ATCC) CCL23] and human aortic endothelial cells (HAECs; Cascade Biologicals, Inc., Portland, OR) were cultured and maintained as previously described (24, 25) .
C. pneumoniae propagation
C. pneumoniae AR-39 (ATCC 53592) was propagated in Hep-2 cell monolayers as previously described (25) . After 72 h of incubation, C. pneumoniae was harvested by mechanical disruption followed by a low-speed (250 g ) centrifugation. Elementary bodies present in the supernatant were pelleted at 30,000 g (JA-20 rotor; Beckman Instruments, Inc., Fullerton, NJ) for 30 min. The pellets were suspended in 0.01 M sodium phosphate (pH 7.2) containing 0.25 mol/l sucrose and 5 mmol/l l -glutamic acid (24, 26) . Titration was performed in cycloheximide-treated Hep-2 cell monolayers grown on round coverslips (25) . Infection of endothelial monolayers (2 ϫ 10 5 cells) was attained by exposure of the cells to C. pneumoniae suspensions diluted in antibiotic-free Medium 200 (Cascade Biologicals) using infective concentrations ranging from 8 ϫ 10 5 to 10 ϫ 10 5 inclusion-forming units (IFUs). These infective concentrations did not cause significant cell death (as assessed by cell morphology, cell attachment, and trypan blue exclusion) and infected 30-40% of cells after 24 h, 60-70% of cells after 48 h, and 100% of cells at 72 h. At least one inclusion body was observed in every cell after 72 h of exposure to C. pneumoniae .
Because the elementary bodies of C. pneumoniae are isolated from Hep-2 cells, preparations of these cells were used as mockinfected cells, which consist of HAECs treated with crude preparations of noninfected Hep-2 cells processed in the same manner as infected Hep-2 cells. Experiments designed to differentiate the effects of active infection from those of surface binding were performed using killed C. pneumoniae elementary bodies obtained either by heating the organism at 95 Њ C for 30 min or by ultraviolet (UV) irradiation for 30 min at 15 cm from the UV source [1,200 ϫ 100 mJ/cm 2 (UVC500; Hoefer, San Francisco, CA)].
Isolation of native LDL and preparation of oxLDL
Blood was collected from healthy volunteers to isolate LDL. Written informed consent as approved by the Review Board for Human Research of the Medical University of South Carolina was signed by all participants. Native LDL (1.019 Ͻ d Ͻ 1.063 g/ml) was isolated from the plasma pools by sequential ultracentrifugation at 60,000 rpm for 24 h at 10 Њ C on a Beckman L-80 ultracentrifuge using a type 60-Ti rotor (Beckman, Palo Alto, CA). Afterward, native LDL was passed through a Sephadex G-25 column (Pharmacia Biotech, Piscataway, NJ) to remove EDTA and then incubated at 37 Њ C in the presence of 40 mM CuCl 2 . Oxidation of LDL was continuously monitored by measuring the formation of fluorescent compounds using a luminescence spectrometer at 360/430 excitation/emission (Bowman ® series 2; Aminco, Rochester, NY) for 12-14 h as described (27) . The freshly oxidized LDL was dialyzed against a solution containing 0.16 M NaCl and 300 mM EDTA and sterilized by passage through a 0.45 mm filter. The protein content of native LDL and oxLDL preparations was measured by the Lowry assay (28).
Incubation of HAECs with native and copper-oxidized LDL
To evaluate the effect of different types of modified LDL on intracellular adhesion molecule-1 (ICAM-1) expression by endothelial cells infected with C. pneumoniae , confluent HAECs (2 ϫ 10 5 cells) were infected with 8 ϫ 10 5 to 10 ϫ 10 5 IFUs of C. pneumoniae elementary bodies at 37 Њ C for 2 h on a rocker platform. After infection, native LDL or oxLDL was added to infected HAECs and noninfected controls. The cells were incubated in the presence of modified LDL for the times and concentrations indicated in the figures. In experiments in which HAECs were incubated with the lipoproteins for more than 48 h, the medium was removed at day 3 and 5 and substituted by fresh medium containing the same concentration of lipoproteins. In some experiments, HAECs were incubated with oxLDL for 72 hr before being infected with C. pneumoniae , and the cells were further incubated for 24 h in the presence of oxLDL.
Immunoblot analysis of ICAM-1
Total cell extracts were prepared using a Triton X buffer [10 mM HEPES, 200 mM NaCl, 2 mM CaCl 2 , 2.5 mM MgCl 2 , and 1.5% (v/v) Triton X] containing 100 g/ml PMSF (Sigma-Aldrich Co., St. Louis, MO) and 10 g/ml leupeptin (Sigma-Aldrich Co.). Cell lysates were centrifuged and the protein concentration in the supernatant determined using the BCA Protein Assay Reagent Kit (Pierce, Rockford, IL). Western blot analysis was performed as described (29) using an anti-human ICAM-1 monoclonal antibody diluted at 1:500 (Calbiochem-Novabiochem, La Jolla, CA). A horseradish peroxidase-conjugated anti-mouse antibody (Calbiochem-Novabiochem) was used as a secondary antibody. ICAM-1 was visualized after incubation of the membranes in Chemiluminescence Reagent Plus (Perkin Elmer Life Science, Inc., Boston, MA) followed by exposure to X-ray film. The films were scanned (Foto/Analyst ® Investigator; Fotodyne, Hartland, WI) (30) , and densitometric analysis (optical density measurements) was performed on a Macintosh computer using the public domain NIH Image program developed at the U.S. National Institutes of Health and available on the Internet at http:// rsb.info.nih.gov/nih-image/. The results are expressed as percentages of the optical density relative to baseline levels found in control HAECs.
Flow cytometry for detection of surface expression of CAMs
Flow cytometry analysis of adhesion molecules was performed as previously described (25) . Confluent HAECs (1.5 ϫ 10 6 ) were at PENN STATE UNIVERSITY, on February 23, 2013 www.jlr.org
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infected for 4 h (for E-selectin determination) or 24 h [for ICAM-1 and vascular cell adhesion molecule-1 (VCAM-1) determination] with C. pneumoniae (15 ϫ 10 6 IFUs). After incubation, ‫ف‬ 2 ϫ 10 5 cells per experiment were incubated with a 1:100 dilution of ICAM-1 or VCAM-1 antibodies (phyco-erythrin-labeled; BD PharMingen, San Diego, CA) or E-selectin antibody solution (FITC-labeled; R&D System, Minneapolis, MA) for 25 min on ice. After one wash with fatty acyl-CoA (FACS) solution, a second wash was performed adding 10% (w/v) propidium iodide. Cells were resuspended in 300 l of FACS solution and immediately processed using a FACS Calibur (Becton Dickinson, San Jose, CA), and the fluorescence emission profile was analyzed by the CellQuest program (Becton Dickinson).
Northern blot analysis
Human ICAM-1 cDNA and VCAM-1 cDNA were provided by Dr. Greve Jeffrey (Bayer Pharmaceutical Division, Berkeley, CA). E-selectin cDNA was provided by Dr. Vivian de Waard (Department of Biochemistry, Academic Medical Center, Amsterdam, The Netherlands). The cDNA probes were obtained after PCR (30 cycles at 95 Њ C, 60 Њ C, and 72 Њ C) using a Qiagen Taq DNA Polymerase Kit (Qiagen, Valencia, CA). Primers for human ICAM-1 (5 Ј -GAG ATC ACC ATG GAG CCA AT-3 Ј and 5 Ј -GGG CCT CAC ACT TCA CTG TC-3 Ј ), VCAM-1 (5 Ј -CAT CCA CAA AGC TGC AAG AA-3 Ј and 5 Ј -CCT GGAT TCC CTT TTC CAG T-3 Ј ), and E-selectin (5 Ј -TGA ACT GTA CAG CCC TGG AA-3 Ј and 5 Ј -AAC TGG GAT TTG CTG TGT CC-3 Ј ) were used (SigmaGenosys, The Woodlands, TX). Human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA was purchased from the ATCC and radiolabeled as described below. Total cellular RNA was isolated from HAECs using an RNeasy Mini Kit (Qiagen) according to the instructions from the manufacturer. Purification and quantification of RNA were assessed by absorption at 260 and 280 nm, and an aliquot of RNA (10 g) from samples with an absorbance ratio Ͼ 1.6 was fractionated using a 1.2% agarose formaldehyde gel. Northern blotting of ICAM-1, VCAM-1, E-selectin, and GAPDH mRNA was performed using the Prime-it ® Rmt Random Primer Labeling Kit according to the instructions provided by the manufacturer (Stratagene, La Jolla, CA) and as previously described (30) .
Data analysis
All data are expressed as means of duplicate samples from three to five independently performed experiments. Data are presented as means Ϯ SD of the percentage of optical density obtained from noninfected HAECs. Comparison between treatments was performed by ANOVA, and the degree of statistical significance was determined by either Mann-Whitney or TukeyKramer test. A value of P Ͻ 0.05 was considered significant.
RESULTS
Expression of ICAM-1 in C. pneumoniae -infected HAECs
Infection of HAECs by C. pneumoniae led to a timedependent increase in the expression of ICAM-1. Relative to the ICAM-1 levels detected in noninfected HAECs (considered as 100%), increased expression of ICAM-1 was observed as early as 2 h after infection (339 Ϯ 199%) and peaked at 12 h after infection (795 Ϯ 93%, P ϭ 0.0012 relative to baseline levels). At 24 h of infection, ICAM-1 levels remained markedly increased (720 Ϯ 184%, P ϭ 0.0104 relative to baseline levels) (Fig. 1) .
The addition of rifampicin, an inhibitor of bacterial DNA-dependent RNA polymerase activity, to HAECs ei- , and 24 h. Noninfected (NI), mocktreated, and tumor necrosis factor (TNF)-treated HAECs were used as controls. After incubation, cells were lysed, and 25 g of protein was electrophoresed by 10% SDS-PAGE. Immunoblotting was performed using an antibody against human ICAM-1 as described in Materials and Methods. Immunoreactive bands were visualized by incubating the membranes with chemiluminescence reagents. The data represent the summary of five different experiments. ICAM-1 levels in noninfected cells were considered as 100%. Levels in C. pneumoniae-infected HAECs are expressed as percentages of the levels in noninfected cells (means Ϯ SD). * P ϭ 0.017. ** P ϭ 0.0012. *** P ϭ 0.0104. (Fig. 2A) . In contrast, heat and UV treatment of C. pneumoniae elementary bodies completely abolished the upregulation of ICAM-1 (Fig. 2B) .
Effect of native LDL and oxLDL on the expression of ICAM-1 by C. pneumoniae-infected HAECs
The results of the immunoblot experiments investigating the effect of native LDL and oxLDL on the expression of ICAM-1 by C. pneumoniae-infected HAECs are summarized in Fig. 3 . Low levels of expression of ICAM-1 were observed in resting, noninfected HAECs. The expression of ICAM-1 by C. pneumoniae-infected HAECs was increased to 900% above the baseline levels detected in noninfected HAECs. The levels of ICAM-1 in infected HAECs exposed to oxLDL were 1,163% above baseline (P ϭ 0.001 compared with the levels in infected cells not exposed to ox-LDL). The addition of native LDL to C. pneumoniae-infected HAECs did not result in a significant increase of ICAM-1 levels.
Because oxLDL further increases the expression of ICAM-1 in C. pneumoniae-infected cells, we decided to determine whether or not this increase was time dependent. 
In mock-treated cells, a slight upregulation of ICAM-1 was observed at both 6 and 24 h. Incubation of noninfected HAECs with 100 g/ml oxLDL from 2 to 24 h induced a small increase in ICAM-1 expression compared with that in resting cells. However, as shown in Fig. 4B , a significantly higher level of ICAM-1 expression was noted when HAECs were infected for 4 h or more with C. pneumoniae (Fig. 4B, left) . The highest level of expression was seen at 12 h after infection. Incubation of C. pneumoniae-infected cells with oxLDL led to even higher levels of expression, mainly at 12 and 24 h (Fig. 4B, right) .
To investigate whether or not upregulation of ICAM-1 expression in C. pneumoniae-infected HAECs would be maintained for more than 24 h, longer time course experiments were performed. As shown in Fig. 4C , -infected HAECs show an increased expression of ICAM-1 up to 7 days after infection, although maximal levels were observed at 48 h. Similarly, enhancement of ICAM-1 expression was caused by exposure of the infected cells to ox-LDL at all time points (Fig. 4C) . pneumoniae-infected HAECs. Noninfected HAECs or HAECs infected with C. pneumoniae (8 ϫ 10 5 IFU/ml) at 37ЊC and 5% CO 2 for 2 h were incubated for 20 h with medium alone, with 100 g/ ml of either native LDL (NLDL) or oxidized LDL (oxLDL), or with 25 U/ml TNF. After incubation, the cells were washed with PBS and lysed. Thirty micrograms of the cell lysates were electrophoresed on a 10% SDS-PAGE gel. Immunoblotting was performed with an antibody against ICAM-1 as described in Materials and Methods. Immunoreactive bands were visualized by incubating the membranes with chemiluminescence reagents. * P ϭ 0.0217. B: Western blot representative of three separate experiments performed in duplicate (TNF in C. pneumoniae-infected cells not shown). Error bars, means Ϯ SEM. To determine whether the effect of oxLDL in the induction of ICAM-1 in C. pneumoniae-infected HAECs was concentration dependent, we treated infected and noninfected HAECs with increasing concentrations of oxLDL (25, 50, 75, 100, and 150 g/ml). As observed in Fig. 4D , treatment of HAECs with oxLDL caused a dose-dependent upregulation of ICAM-1 expression in both infected and noninfected cells. The effect of oxLDL on ICAM-1 expression in C. pneumoniae-infected HAECs was greater than that observed in noninfected HAECs. In infected HAECs, treatment with 25 g/ml oxLDL had a minimal effect on ICAM-1 expression, which was already enhanced as a consequence of infection. In contrast, concentrations of oxLDL equal to or greater than 50 g/ml had a marked synergistic effect on the expression of ICAM-1 by C. pneumoniae-infected HAECs. Incubation of HAECs with 100 g/ml oxLDL for 72 h before C. pneumoniae infection led to an upregulation of ICAM-1 expression (Fig. 5) . The effect of oxLDL in upregulating ICAM-1 expression seems to be more marked in cells in which oxLDL was added after infection with C. pneumoniae.
Flow cytometry analysis of ICAM-1, VCAM-1, and E-selectin expression in C. pneumoniae-infected HAECs
Flow cytometry studies were performed to quantify the surface expression of ICAM-1 in C. pneumoniae-infected cells incubated in the presence or absence of oxLDL (Fig.  6A) . Surface expression of ICAM-1 was observed in 51.2 were pretreated for 72 h with 100 g/ml oxLDL followed by infection with C. pneumoniae (8 ϫ 10 5 IFUs) for 24 h (oxLDLx3dϩCp) or infected with C. pneumoniae for 2 h and then incubated with ox-LDL for 24 h (CpϩoxLDL). Noninfected (NI) and C. pneumoniaeinfected HAECs were used as controls. Cell lysates were prepared, electrophoresed, and immunoblotted as described in Materials and Methods using an anti-human ICAM-1 antibody. Experiments were run in duplicate. -1) , and E-selectin expression in C. pneumoniae-infected HAECs. Confluent HAECs (1.5 ϫ 10 6 cells) were infected with C. pneumoniae (Cp; 10 ϫ 10 6 IFUs) and incubated with medium alone or with oxLDL (100 g/ml) for 18 h. Noninfected HAECs were used as controls. After incubation, cells were washed and detached. Cell suspensions were collected, and ‫2ف‬ ϫ 10 5 cells were incubated with Phyco-erythrin (PE)-labeled ICAM-1 (A), PE-labeled VCAM-1 (B), or FITC-labeled E-selectin (C) (1:100) antibodies or isotype control solutions. Cells were processed using a fatty acyl-CoA Calibur (Becton Dickinson). Results are representative of two separate flow cytometry analyses performed in duplicate for ICAM-1 or three separate flow cytometry analyses of VCAM-1 and E-selectin. Geo, geometric; % gate, percent of cells included in the defined gate; Y geometric, geometric mean of fluorescence intensity (FL2-H) in gated cells.
at PENN STATE UNIVERSITY, on February 23, 2013 www.jlr.org Downloaded from fected cells occurred at the transcriptional level, ICAM-1, VCAM-1, and E-selectin mRNA levels in C. pneumoniaeinfected cells incubated in the presence or absence of ox-LDL (100 g/ml) were assessed by Northern blot analysis. Confluent HAECs were infected with C. pneumoniae for 2 h and incubated with or without 100 g/ml oxLDL at different time points after infection. As controls, we used noninfected cells, resting cells, and TNF-treated (25 U/ml) noninfected cells.
As observed in Fig. 7A , ICAM-1 mRNA levels were very low in noninfected control HAECs. Infection with C. pneumoniae alone induced a rapid increase in the level of ICAM-1 mRNA. The maximum increase (eight times the baseline level) was achieved within 2-4 h after the addition of C. pneumoniae to the endothelial cell monolayers, and the mRNA levels decreased to baseline levels after 8 h. The addition of 100 g/ml oxLDL to infected cells had no discernible effect on ICAM-1 mRNA levels.
For VCAM-1 and E-selectin, Northern blot analysis showed a short-lived induction of mRNA transcripts by C. pneumoniae for both adhesion molecules. Maximum expression of VCAM-1 and E-selectin mRNA was observed at 2 h after infection, but it was markedly decreased at 4 h and not detectable at later time points. The addition of oxLDL to infected cells had no discernible effect on the level of VCAM-1 and E-selectin transcripts (Fig. 7A, B) .
DISCUSSION
Our results show that the expression of adhesion molecules in HAECs infected with C. pneumoniae AR39 is enhanced when the cells are incubated in medium containing oxLDL. The effect of oxLDL on ICAM-1 expression by C. pneumoniae-infected cells was concentration dependent, rapid and sustained, and more prominent when oxLDL was added after infection. In fact, the effect of oxLDL was seen as early as 12 h after infection and persisted for 7 days. The enhancement of ICAM-1 upregulation, however, was not observed in the presence of native LDL. Advanced glycation end product-LDL was also tested and did not enhance the upregulation of ICAM-1 (data not shown). These results strongly suggest that oxLDL plays a role in regulating the adhesion of monocytes to C. pneumoniae-infected endothelial cells by further enhancing the expression of ICAM-1 promoted by C. pneumoniae.
Interestingly, both C. pneumoniae and oxLDL have been shown to activate Nuclear factor B (NF-B). Given the well-established role of NF-B as a transcription factor for CAM genes, including the genes encoding E-selectin, ICAM-1, and VCAM-1 (31), it seems likely that the synergistic effect on ICAM-1 expression observed in C. pneumoniae-infected HAECs is a consequence of the activation of NF-B. Several reports indicate that oxLDL activates signaling pathway(s) upon ligation to the scavenger receptor and that NF-B activation is mediated via protein kinase C (PKC)-and/or calcium-dependent pathways (32) . In previously reported studies (33) , we have demonstrated that HAECs, within 30 min of exposure to C. pneumoniae, show Fig. 7 . Effect of oxLDL on the upregulation of ICAM-1, VCAM-1, and E-selectin mRNA in C. pneumoniae-infected HAECs. Confluent HAECs (1.5 ϫ 10 6 cells) were infected with C. pneumoniae (10 ϫ 10 6 IFUs) alone or C. pneumoniae (Cp; 3 ϫ 10 6 IFUs/ml) and oxLDL (100 g/ml) for 2, 4, 8, 12, and 24 h. Noninfected (NI) cells and HAECs treated with TNF (25 U/ml) were used as controls. Ten micrograms of RNA isolated from infected and noninfected cells was subjected to electrophoresis on a 1.2% agarose formaldehyde gel and transferred to a nylon membrane. The ICAM-1, VCAM-1, E-selectin, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNAs immobilized on the membrane were hybridized with 32 Plabeled cDNAs as described in Materials and Methods. Data are representative of three separate experiments (n ϭ 3).
We also used flow cytometry analysis to measure VCAM-1 expression in C. pneumoniae-infected HAECs incubated with or without oxLDL (Fig. 6B) . Our results showed that in contrast to ICAM-1, VCAM-1 was not constitutively expressed by HAECs. After HAEC infection by C. pneumoniae, only 9.3 Ϯ 0.7% were positive for VCAM-1 expression after 24 h of infection (Fig. 6B) , and VCAM-1 expression was no longer noted at 48 h after infection (data not shown). In contrast to ICAM-1, the addition of oxLDL led to a decrease in VCAM-1 surface expression (1.6 Ϯ 0.7%) in C. pneumoniae-infected HAECs.
Finally, as shown in Fig. 6 , in noninfected HAECs the baseline expression of E-selectin was very low (1.1 Ϯ 0.15%). Stimulation of noninfected cells with oxLDL resulted in a significant increase in E-selectin expression relative to noninfected controls (7.72 Ϯ 0.2%, P Ͻ 0.05, n ϭ 3) (Fig. 6A) . C. pneumoniae infection induced significant surface expression of E-selectin on 52.2 Ϯ 3.4% of the cells (P Ͻ 0.001 relative to noninfected cells, n ϭ 3) at 5 h of infection (Fig. 7B) . In C. pneumoniae-infected HAECs, oxLDL (100 g/ml) resulted in E-selectin expression in 63.64 Ϯ 1.09% of the cells (P Ͻ 0.001 vs. C. pneumoniaeinfected cells) (Fig. 6B) .
Effect of oxLDL in the transcriptional activation of adhesion molecule mRNA in C. pneumoniae-infected HAECs
To further investigate whether the mechanism by which oxLDL-induced upregulation of adhesion molecules in in-translocation of PKC from the cytosol to the membrane followed by NF-B activation, which resulted in increased ICAM-1 gene expression. The receptors to which C. pneumoniae binds to induce the activation of signaling pathways leading to ICAM-1 upregulation are not known.
The lack of effect on CAM expression observed in HAECs incubated with heat-treated and UV-inactivated C. pneumoniae, as shown in Fig. 2B and as previously described (33) , strongly suggests that CAM expression requires the exposure of HAECs to viable C. pneumoniae elementary bodies or nonoxidized C. pneumoniae proteins. Heat inactivation does not affect chlamydial lipopolysaccharide (LPS); therefore, the lack of ICAM-1 upregulation in cells incubated with heat-inactivated C. pneumoniae excludes LPS as the mediator. UV irradiation, in contrast to heat inactivation, will not lead to the denaturing of proteins but may lead to their oxidative modification and therefore modify their behavior and binding activity. The present study also demonstrates that the effect of C. pneumoniae in ICAM-I upregulation is not secondary to the de novo synthesis of a chlamydial protein, because inhibition of bacterial protein synthesis by rifampicin at different stages of the chlamydial cell cycle did not affect the ability of C. pneumoniae to induce ICAM-1 expression.
The effects of C. pneumoniae by itself or in synergism with oxLDL on the expression of CAMs of the immunoglobulin superfamily are more pronounced for ICAM-1 than for any of the other adhesion molecules studied. This is not surprising. It has been previously reported (12, 21) that preferential upregulation of ICAM-1 takes place in C. pneumoniae-infected human umbilical venous endothelial cells (HUVECs) and HAECs. Also, exposure of arterial endothelial cells to oxLDL (11, 34, 35) or native LDL (10) has been shown to lead to a higher level of expression for ICAM-1 and to lower or no expression for VCAM-1 and E-selectin. Few studies examining the effect of modified lipoproteins in E-selectin expression have been reported, and the few studies published are not always concordant. Stimulation of HUVECs with endothelin-1 with and without the addition of oxLDL did not induce cell surface expression of E-selectin in endothelial cells (36) . However, incubation of endothelial cells with native LDL (500 g/ml) led to a small increase of E-selectin expression in human coronary artery endothelial cells (37, 38) . In our experimental conditions, E-selectin expression was not significantly induced by high levels of native LDL (data not shown), but oxLDL was able to further increase the proportion of E-selectin-positive cells at 4 h after infection, further reinforcing the conclusion that ox-LDL and C. pneumoniae act synergistically in the induction of CAM expression by HAECs.
Taken together, our findings indicate that C. pneumoniae-infected endothelial cells tend to express ICAM-1 and E-selectin and that exposure of infected cells to oxLDL further enhances the expression of these two CAMs. Adhesion molecules play a critical role in the progression of atherogenesis, particularly ICAM-1, which appears to be the adhesion molecule responsible for the earliest changes in vascular adhesiveness (38, 39) . The exact molecular mechanisms involved in the upregulation of ICAM-1 by C. pneumoniae and oxLDL are not clear. The involvement of pathways leading to the PKC activation of NF-B seems very likely, but the exact nature of the receptors involved and of the early signals delivered by C. pneumoniae and by oxLDL requires further investigation.
In conclusion, our data prove that, at least in vitro, two independent insults believed to play significant roles in the initiation and/or perpetuation of atherosclerotic vascular disease have a synergistic effect at the level of the endothelium. Of note is the fact that a synergistic interaction between hyperlipidemia and C. pneumoniae had been demonstrated in animal studies. In mice with low density lipoprotein receptor deficiency, C. pneumoniae failed to induce atherosclerosis by itself, but when the same mice were infected with C. pneumoniae AR39 and fed a highcholesterol diet, infection significantly exacerbated the hypercholesterolemia-induced atherosclerosis (40) . Recently, it was also shown that C. pneumoniae infection can enhance intimal thickening and atherosclerotic changes in New Zealand White rabbits fed 0.25% cholesterolenriched chow (41) . The direct correlation between hyperlipidemia and LDL oxidation (23, 42, 43) links the two separate observations, suggesting that an increased generation of oxLDL in hyperlipidemic animals may be one of the reasons behind the synergistic effects of C. pneumoniae and hyperlipidemia.
Further characterization of the complex regulatory mechanisms involved in the upregulation of ICAM-1 by C. pneumoniae in HAECs and other cells involved in the atherosclerotic process will further our understanding of the C. pneumoniae-induced inflammatory component in atherosclerosis. That may contribute to the development of new strategies to modulate the course of the chronic inflammatory process in atherosclerosis and likely to the development of therapeutic tools to halt the progression of arteriosclerosis.
